Literature DB >> 10025964

The DNA binding activity of Translin is mediated by a basic region in the ring-shaped structure conserved in evolution.

K Aoki1, K Suzuki, R Ishida, M Kasai.   

Abstract

DNA binding proteins, for the most part, function as dimers or tetramers which recognize their target sequences. Here we show that Translin, a novel single-stranded DNA end binding protein, forms a ring-shaped structure conserved throughout evolution and that this structure is responsible for its DNA binding activity. Point mutations at Leu184 and Leu191 in the leucine zipper motif of human Translin resulted in loss of the multimeric structure and abrogation of DNA binding. Point mutations at R86, H88, H90 to T86, N88, N90 in one of the basic regions, however, completely inhibited the DNA binding activity without affecting the multimeric structure. These results support the view that the DNA binding domain of Translin is formed in the ring-shaped structure in combination with its basic region (amino acids 86-97) polypeptides.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10025964     DOI: 10.1016/s0014-5793(99)00010-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

Review 1.  Candidate RNA-binding proteins regulating extrasomatic mRNA targeting and translation in mammalian neurons.

Authors:  Stefan Kindler; Michaela Monshausen
Journal:  Mol Neurobiol       Date:  2002-04       Impact factor: 5.590

2.  Analysis of nucleic acid binding by a recombinant translin-trax complex.

Authors:  Matthew Lluis; Warren Hoe; Jennifer Schleit; Jon Robertus
Journal:  Biochem Biophys Res Commun       Date:  2010-05-05       Impact factor: 3.575

3.  Characterization of a plant (rice) translin and its comparative analysis with human translin.

Authors:  Rajani Kant Chittela; Gagan Deep Gupta; Anand Ballal
Journal:  Planta       Date:  2014-05-27       Impact factor: 4.116

4.  Functional characterization of Drosophila Translin and Trax.

Authors:  Maike Claussen; Rafael Koch; Zhao-Yang Jin; Beat Suter
Journal:  Genetics       Date:  2006-10-08       Impact factor: 4.562

5.  Altering the GTP binding site of the DNA/RNA-binding protein, Translin/TB-RBP, decreases RNA binding and may create a dominant negative phenotype.

Authors:  V M Chennathukuzhi; Y Kurihara; J D Bray; J Yang; N B Hecht
Journal:  Nucleic Acids Res       Date:  2001-11-01       Impact factor: 16.971

Review 6.  The Translin/Trax RNA binding complex: clues to function in the nervous system.

Authors:  Zhi Li; Yen Wu; Jay M Baraban
Journal:  Biochim Biophys Acta       Date:  2008-04-03

7.  Mice deficient for testis-brain RNA-binding protein exhibit a coordinate loss of TRAX, reduced fertility, altered gene expression in the brain, and behavioral changes.

Authors:  Vargheese Chennathukuzhi; Joel M Stein; Ted Abel; Stacy Donlon; Shicheng Yang; Juli P Miller; David M Allman; Rebecca A Simmons; Norman B Hecht
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

8.  translin Is Required for Metabolic Regulation of Sleep.

Authors:  Kazuma Murakami; Maria E Yurgel; Bethany A Stahl; Pavel Masek; Aradhana Mehta; Rebecca Heidker; Wesley Bollinger; Robert M Gingras; Young-Joon Kim; William W Ja; Beat Suter; Justin R DiAngelo; Alex C Keene
Journal:  Curr Biol       Date:  2016-03-24       Impact factor: 10.834

9.  The BTB/POZ domain of the Arabidopsis disease resistance protein NPR1 interacts with the repression domain of TGA2 to negate its function.

Authors:  Patrick Boyle; Errol Le Su; Amanda Rochon; Heather L Shearer; Jhadeswar Murmu; Jee Yan Chu; Pierre R Fobert; Charles Després
Journal:  Plant Cell       Date:  2009-11-13       Impact factor: 11.277

10.  Mapping of interaction sites of the Schizosaccharomyces pombe protein Translin with nucleic acids and proteins: a combined molecular genetics and bioinformatics study.

Authors:  Elad Eliahoo; Ron Ben Yosef; Laura Pérez-Cano; Juan Fernández-Recio; Fabian Glaser; Haim Manor
Journal:  Nucleic Acids Res       Date:  2010-01-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.